Brazil's Anvisa recalls three lots of antibiotic Hytamicina over foreign body contamination

Brazil's health regulator Anvisa ordered a recall of three lots of the antibiotic Hytamicina after detecting a foreign body in the product. The contamination poses a quality and safety risk to patients, though the specific nature of the foreign body and any reported adverse events remain undisclosed. This is a regulatory action with limited direct market impact, but it highlights ongoing pharmaceutical quality control concerns in Brazil.